Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

October 14, 2007

Primary Completion Date

September 8, 2011

Study Completion Date

September 8, 2011

Conditions
Oropharyngeal CandidiasisCandidemiaInvasive CandidiasisEsophageal Candidiasis
Interventions
DRUG

Micafungin

IV

Trial Locations (13)

1500

Benmed Park Clinic, Benoni

3610

St. Mary's Hospital, Mariannhill

7824

2 Military Hospital, Wynberg

7924

Grootte Schuur Hospital, Cape Town

27710

Duke University Medical Center, Durham

64108

Children's Mercy Hospital, Kansas City

75390

University of Texas Southwestern, Dallas

77030

Texas Children's Hospital, Houston

90095

University of California Los Angeles Medical Center, Los Angeles

92868

Children's Hospital of Orange County, Orange

97239

Oregon Health and Science University, Portland

0039

GCT -Sunnyside Medi-clinic, Lynn East

0400

Jubilee Hospital, Themba

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY